Aura Biosciences (AURA)

• Market cap: $373M
• 1 day: 6%
• 5 days: -1.48%
• 1 month: -2.44%
• 3 months: -11.23%
• 6 months: 7.9%
• Year to date: -27.24%
• 1 year: -48.41%
• 5 years: -59.39%
• 10 years: -59.39%
• Sector: Healthcare
• Industry: Biotechnology

About: Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Employees: 106